Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
Histocell, SL
RED RED
R&D Programs
Histocell's core activity is the development of novel Cell therapy and Tissue engineering products. This is achieved through a number of R&D programs in several fields of interest.
 
The company's R&D programs are based on the use of hAMSCs obtained from adipose tissue, wich are then pre-differentiated in vitro to different cell lineages to match the desired application. These are then combined with advanced bioactive materials/scaffolds in order to enhance the therapeutic potential of the product which will be finally implanted in the patient's body. Histocell's R&D programs are currently focused on the following fields: Cartilage regeneration, Bone regeneration, Advanced wound healing, Neuroprotection and Pulmonary therapy.
 
 
 
 
Permalink: http://www.mercadosbiotecnologicos.com/?iid=24&own=2&itid=3&lan=en
 
Search